Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
The use of fluoroquinolones and musculoskeletal adverse events in pediatrics : a longitudinal cohort study
- At: 2017 FIP Congress in Seoul (South Korea)
- Type: Poster
- By: KIM, Yoonhye (Korea, Republic Of)
- Co-author(s): Yoonhye Kim: Evidence based research Lab. Division of Clinical pharmacotherapy, College of Pharmacy, Chungang university, Seoul, Korea, Republic Of
Eunyoung Kim: Evidence based research Lab. Division of Clinical pharmacotherapy, College of Pharmacy, Chungang university, Seoul, Korea, Republic Of
BackgroundPediatric use of FQs has been restricted due to early findings of FQ-associated weight-bearing joint damage in juvenile animals. However, the off-label pediatric use of FQ is thought to be common and increasing worldwide.
PurposeTo analyze prescription patterns of quinolones in patients under 18 years and to access the incidence and risk.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019